SRES 510
118th Congress
Senate
Health
A resolution expressing the sense of the Senate that the scientific judgement of the Food and Drug Administration that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable and based on science.
Introduced: December 14, 2023
Introduced by:
Warren, Elizabeth
Democratic
· Massachusetts
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 14, 2023
Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S6003-6004)
Dec 14, 2023
Introduced in Senate
Plain-English summary
This resolution expresses the sense of the Senate that (1) policies governing access to medication abortion care should be based on scientific review by the Food and Drug Administration (FDA), and (2) the FDA has found mifepristone to be safe and effective for women seeking abortions.
What's happening now
Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S6003-6004)
Committees of jurisdiction
1